<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05050708</url>
  </required_header>
  <id_info>
    <org_study_id>Gyn.smerte.op.risiko.21</org_study_id>
    <nct_id>NCT05050708</nct_id>
  </id_info>
  <brief_title>Riskfactors of Post-operative Pain and Nausea After Ambulatory Gynaecological Laparocopy.</brief_title>
  <official_title>Risikofaktorer for Postoperativ Smerte og Kvalme Etter Dagkirurgisk Gynekologisk Laparoskopi</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient due for elective, ambulatory gynaecological laparoscopy will be screened&#xD;
      peri-operatively for known and potential risk factors of postoperative pain and&#xD;
      nausea/vomiting.&#xD;
&#xD;
      The actual incidence and severity of pain and nausea/vomiting will be recorded during th 0-24&#xD;
      hr intervall after end of surgery, as well as the doses of all drugs, given for either&#xD;
      prophylaxis or treatment&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 24, 2021</start_date>
  <completion_date type="Anticipated">July 25, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 25, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>0-24 hours</time_frame>
    <description>Numerical Ratings Score (NRS) Scale 0-10, 10 is worst</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative nausea</measure>
    <time_frame>0-24 hours</time_frame>
    <description>yes/no, Numerical Rating Score (NRS), Scale 0-10, 10 is worst</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peri-operative nausea risk score</measure>
    <time_frame>preop, 0-24 hours post-operatively</time_frame>
    <description>Apfel score, 0-4 (4 is maximal risk).Based on a number of registrations, such as: smoking status, postoperative opioid effects, smoking status, travel sickness, previous nause or vomiting after surgery/anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-operative pain risk score</measure>
    <time_frame>preop, 0-24 hours</time_frame>
    <description>Based on a number of registrations, such as: age, sosio-economic status, pre-op pain, pre-op use of opioids, pre-op anxiety or depression, pre-op catastrophizing, pre-op expectations, type of surgery, type of anaesthesia, lenght/ivasive ness of surgery, peri-op drug consumtion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op fatigue</measure>
    <time_frame>0-24 hrs</time_frame>
    <description>Christensen score, 0-10, 10 is maximal fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op function</measure>
    <time_frame>0-24hr</time_frame>
    <description>Everyday function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op analgesia consumption</measure>
    <time_frame>0-24hr</time_frame>
    <description>number of opioid equivalents consumed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op anti-emetic drug consumption</measure>
    <time_frame>0-24hr</time_frame>
    <description>type and dose of ante-emetic medication</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Nausea</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient interview</intervention_name>
    <description>Patient will be interviewed pre-operatively and at 24 hrs post-opartively</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult females&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective adult patients due for planned ambulatory gynaecological laparoscopy&#xD;
&#xD;
          -  Must be able to speak and write in Norwegian language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who, for some reason, is transferred to non-ambulatory (same day discharge)&#xD;
             care.&#xD;
&#xD;
          -  Patients who, for some reason, have a change in surgical procedure from laparoscopy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Eligibility is based on self representation of gender identity</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Raeder, MD, PhD</last_name>
      <phone>004792249669</phone>
      <email>johan.rader@medisin.uio.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 23, 2021</study_first_submitted>
  <study_first_submitted_qc>September 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Johan C RÃ¦der</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

